FDA Warning Letter — Marriott 764

Case 672497 — FEI 3029953925

The FDA took a Warning Letter action against Marriott 764 on Nov 28, 2023 (Anaheim, CA). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Marriott 764
Date
Nov 28, 2023
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Anaheim, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.